应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02157 乐普生物-B
交易中 04-19 14:47:26
4.250
-0.050
-1.16%
最高
4.550
最低
3.990
成交量
238.00万
今开
3.990
昨收
4.300
日振幅
13.02%
总市值
70.53亿
流通市值
68.22亿
总股本
16.59亿
成交额
1,041万
换手率
0.15%
流通股本
16.05亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
乐普生物-B(02157)股价上升5.116%,现价港币$4.52
阿斯达克财经 · 11:41
乐普生物-B(02157)股价上升5.116%,现价港币$4.52
乐普生物-B(02157)股价显著波动12.326%,现价港币$4.52
阿斯达克财经 · 11:41
乐普生物-B(02157)股价显著波动12.326%,现价港币$4.52
乐普生物-B盘中异动 早盘急速跳水7.19%报3.991港元
自选股智能写手 · 09:31
乐普生物-B盘中异动 早盘急速跳水7.19%报3.991港元
乐普生物-B04月18日主力资金流出66万元 连续3日减仓
自选股智能写手 · 04-18 16:16
乐普生物-B04月18日主力资金流出66万元 连续3日减仓
乐普生物-B(02157)股价下跌8.471%,现价港币$3.89
阿斯达克财经 · 04-16
乐普生物-B(02157)股价下跌8.471%,现价港币$3.89
乐普生物-B盘中异动 急速跳水5.41%
自选股智能写手 · 04-16
乐普生物-B盘中异动 急速跳水5.41%
乐普生物-B早盘大涨近15% 新药临床试验完成受试者首次给药
新浪港股 · 04-15
乐普生物-B早盘大涨近15% 新药临床试验完成受试者首次给药
【港股通】乐普生物(02157)拉升至14.88% 治疗晚期实体瘤药物临床首例受试者完成首次给药
金吾财讯 · 04-15
【港股通】乐普生物(02157)拉升至14.88% 治疗晚期实体瘤药物临床首例受试者完成首次给药
乐普生物-B(02157)上涨11.75%,报4.28元/股
金融界 · 04-15
乐普生物-B(02157)上涨11.75%,报4.28元/股
港股异动 | 乐普生物-B(02157)涨超4% 治疗晚期实体瘤药物临床试验完成首例受试者首次给药
智通财经 · 04-15
港股异动 | 乐普生物-B(02157)涨超4% 治疗晚期实体瘤药物临床试验完成首例受试者首次给药
乐普生物-B盘中异动 大幅上涨5.19%
自选股智能写手 · 04-15
乐普生物-B盘中异动 大幅上涨5.19%
乐普生物(02157.HK)治疗晚期实体瘤药物临床试验完成首例受试者首次给药
阿斯达克财经 · 04-15
乐普生物(02157.HK)治疗晚期实体瘤药物临床试验完成首例受试者首次给药
乐普生物-B(02157):AstraZeneca已就CMG901治疗晚期实体瘤开展多项临床研究
智通财经 · 04-15
乐普生物-B(02157):AstraZeneca已就CMG901治疗晚期实体瘤开展多项临床研究
乐普生物-B盘中异动 股价大涨5.16%
自选股智能写手 · 04-11
乐普生物-B盘中异动 股价大涨5.16%
乐普生物-B(02157)上涨5.52%,报3.82元/股
金融界 · 04-10
乐普生物-B(02157)上涨5.52%,报3.82元/股
乐普生物-B盘中异动 快速拉升5.52%报3.821港元
自选股智能写手 · 04-10
乐普生物-B盘中异动 快速拉升5.52%报3.821港元
乐普生物-B(02157)股价上升5.249%,现价港币$3.81
阿斯达克财经 · 04-10
乐普生物-B(02157)股价上升5.249%,现价港币$3.81
乐普生物-B(02157)上涨5.12%,报3.49元/股
金融界 · 04-08
乐普生物-B(02157)上涨5.12%,报3.49元/股
乐普生物-B盘中异动 快速上涨5.12%
自选股智能写手 · 04-08
乐普生物-B盘中异动 快速上涨5.12%
乐普生物-B(02157)股价上升5.12%,现价港币$3.49
阿斯达克财经 · 04-08
乐普生物-B(02157)股价上升5.12%,现价港币$3.49
加载更多
公司概况
公司名称:
乐普生物-B
所属市场:
SEHK
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"02157","market":"HK","secType":"STK","nameCN":"乐普生物-B","latestPrice":4.25,"timestamp":1713509199105,"preClose":4.3,"halted":0,"volume":2380000,"delay":0,"floatShares":1605176474,"shares":1659444838,"eps":-0.014382327,"marketStatus":"交易中","marketStatusCode":2,"change":-0.05,"latestTime":"04-19 14:47:26","open":3.99,"high":4.55,"low":3.99,"amount":10408050,"amplitude":0.130233,"askPrice":4.26,"askSize":1000,"bidPrice":4.23,"bidSize":5000,"shortable":3,"etf":0,"ttmEps":-0.014382327146716787,"exchange":"SEHK","tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1713514200000},"adr":0,"listingDate":1645545600000,"adjPreClose":4.3,"openAndCloseTimeList":[[1713490200000,1713499200000],[1713502800000,1713513600000]],"volumeRatio":0.941889,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02157/","defaultTab":"news","newsList":[{"id":"2428506238","title":"乐普生物-B(02157)股价上升5.116%,现价港币$4.52","url":"https://stock-news.laohu8.com/highlight/detail?id=2428506238","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2428506238?lang=zh_cn&edition=full","pubTime":"2024-04-19 11:41","pubTimestamp":1713498060,"startTime":"0","endTime":"0","summary":"[上升股]乐普生物-B(02157) 股价在上午11:41比前收市价上升5.116%,现股价为港币$4.52。至目前为止,今日最高价为$4.52,而最低价为$3.99。总成交量为92.4万股,总成交金额为港币$401.424万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180725133914771_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180725133914771_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2404191960/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2428236506","title":"乐普生物-B(02157)股价显著波动12.326%,现价港币$4.52","url":"https://stock-news.laohu8.com/highlight/detail?id=2428236506","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2428236506?lang=zh_cn&edition=full","pubTime":"2024-04-19 11:41","pubTimestamp":1713498060,"startTime":"0","endTime":"0","summary":"[异动股]乐普生物-B(02157) 股价在上午11:41出现显著波动12.326%,现股价为港币$4.52,比前收市价上升5.116%4.651%。至目前为止,今日最高价为$4.52,而最低价为$3.99。总成交量为92.6万股,总成交金额为港币$402.328万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205154958317_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205154958317_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAC24041933/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2428303579","title":"乐普生物-B盘中异动 早盘急速跳水7.19%报3.991港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428303579","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428303579?lang=zh_cn&edition=full","pubTime":"2024-04-19 09:31","pubTimestamp":1713490288,"startTime":"0","endTime":"0","summary":"2024年04月19日早盘09时31分,乐普生物-B股票出现异动,股价大幅下挫7.19%。截至发稿,该股报3.991港元/股,成交量2.2万股,换手率0.00%,振幅0.00%。资金方面,该股资金流入0港元,流出1.197万港元。乐普生物-B股票所在的生物技术行业中,整体涨幅为0.24%。乐普生物-B公司简介:乐普生物科技股份有限公司是一家专注于肿瘤治疗领域的中国生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419093128861e7292&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419093128861e7292&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428355941","title":"乐普生物-B04月18日主力资金流出66万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2428355941","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428355941?lang=zh_cn&edition=full","pubTime":"2024-04-18 16:16","pubTimestamp":1713428188,"startTime":"0","endTime":"0","summary":"04月18日, 乐普生物-B股价涨2.38%,报收4.30元,成交金额866万元,换手率0.13%,振幅5.00%,量比0.63。乐普生物-B今日主力资金净流出66万元,连续3日净流出,上一交易日主力净流出94万元,今日环比减少29.79%。该股近5个交易日上涨15.34%,主力资金累计净流出360万元;近20日主力资金累计净流出354万元,其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181617088b34bf93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181617088b34bf93&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427958869","title":"乐普生物-B(02157)股价下跌8.471%,现价港币$3.89","url":"https://stock-news.laohu8.com/highlight/detail?id=2427958869","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2427958869?lang=zh_cn&edition=full","pubTime":"2024-04-16 10:14","pubTimestamp":1713233640,"startTime":"0","endTime":"0","summary":"[下跌股]乐普生物-B(02157) 股价在上午10:14比前收市价下跌8.471%,现股价为港币$3.89。至目前为止,今日最高价为$4.2,而最低价为$3.89。总成交量为132.7万股,总成交金额为港币$537.874万。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180126135510179_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180126135510179_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2404161239/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2427426868","title":"乐普生物-B盘中异动 急速跳水5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427426868","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427426868?lang=zh_cn&edition=full","pubTime":"2024-04-16 09:51","pubTimestamp":1713232266,"startTime":"0","endTime":"0","summary":"2024年04月16日早盘09时51分,乐普生物-B股票出现异动,股价快速下挫5.41%。截至发稿,该股报4.020港元/股,成交量82.1万股,换手率0.05%,振幅4.47%。乐普生物-B股票所在的生物技术行业中,整体跌幅为0.29%。乐普生物-B公司简介:乐普生物科技股份有限公司是一家专注于肿瘤治疗领域的中国生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240416095106861e5fe7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240416095106861e5fe7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427476014","title":"乐普生物-B早盘大涨近15% 新药临床试验完成受试者首次给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2427476014","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2427476014?lang=zh_cn&edition=full","pubTime":"2024-04-15 12:01","pubTimestamp":1713153660,"startTime":"0","endTime":"0","summary":"乐普生物-B早盘持续上扬,现涨14.88%,报4.40港元,成交额1572.265万港元。当中,一项在表达Claudin 18.2的晚期或转移性胃及胃食管结合部腺癌受试者中比较CMG901单药与研究者选择的方案作为二线或二线以上治疗的国际多中心III期研究,已于今年3月在药物临床试验登记与信息平台进行公示,首例受试者已于4月11日完成首次给药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-04-15/doc-inarwtzw3727463.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-04-15/doc-inarwtzw3727463.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2427019015","title":"【港股通】乐普生物(02157)拉升至14.88% 治疗晚期实体瘤药物临床首例受试者完成首次给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2427019015","media":"金吾财讯","top":-1,"share":"https://www.laohu8.com/m/news/2427019015?lang=zh_cn&edition=full","pubTime":"2024-04-15 11:22","pubTimestamp":1713151346,"startTime":"0","endTime":"0","summary":"金吾财讯 | 乐普生物 股价短线拉高,截至发稿,报4.4港元,涨14.88%,成交额946.71万港元。消息面上,有关其与康诺亚成立的合营企业KY与AstraZeneca订立全球独家许可协议,以开发及商业化CMG901。截止公告日期,AstraZeneca已就CMG901治疗晚期实体瘤开展了多项临床研究。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210810/MDE2Mjg1ODkyMTQzNDI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/MDE2Mjg1ODkyMTQzNDI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1935036","is_publish_highlight":false,"gpt_icon":0},{"id":"2427165200","title":"乐普生物-B(02157)上涨11.75%,报4.28元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2427165200","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2427165200?lang=zh_cn&edition=full","pubTime":"2024-04-15 10:57","pubTimestamp":1713149870,"startTime":"0","endTime":"0","summary":"4月15日,乐普生物-B(02157)盘中上涨11.75%,截至10:57,报4.28元/股,成交386.69万元。乐普生物科技股份有限公司是一家专注于肿瘤治疗领域的创新型生物制药企业,主要通过自主创新和战略合作构建有市场差异化的生物药产品管线,并致力于建立并加强自主生产能力,实现产品的国内商业化和国际市场推广。截至2023年年报,乐普生物-B营业总收入2.25亿元、净利润-2209.6万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/15105740237071.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2427015640","title":"港股异动 | 乐普生物-B(02157)涨超4% 治疗晚期实体瘤药物临床试验完成首例受试者首次给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2427015640","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2427015640?lang=zh_cn&edition=full","pubTime":"2024-04-15 10:49","pubTimestamp":1713149362,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,乐普生物-B(02157)涨超4%,截至发稿,涨4.18%,报3.99港元,成交额193.32万港元。消息面上,乐普生物公布,有关其与康诺亚成立的合营企业KYM与AstraZeneca订立许可协议以开发及商业化CMG901,目前,AstraZeneca已就CMG901治疗晚期实体瘤开展多项临床研究。其中,一项在表达Claudin 18.2的晚期或转移性胃及胃食管结合部腺癌受试者中比较CMG901单药与研究者选择的方案作为二线或二线以上治疗的国际多中心III期研究已于2024年3月在药物临床试验登记与信息平台进行公示,首例受试者已于2024年4月11日完成首次给药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1102351.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2427091709","title":"乐普生物-B盘中异动 大幅上涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427091709","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427091709?lang=zh_cn&edition=full","pubTime":"2024-04-15 09:38","pubTimestamp":1713145080,"startTime":"0","endTime":"0","summary":"2024年04月15日早盘09时38分,乐普生物-B股票出现波动,股价急速拉升5.19%。截至发稿,该股报4.030港元/股,成交量17.6万股,换手率0.01%,振幅3.13%。乐普生物-B股票所在的生物技术行业中,整体跌幅为0.03%。其相关个股中,乐普生物-B、泰格医药、3D MEDICINES涨幅较大,振幅较大的相关个股有药明合联、圣诺医药-B、云顶新耀-B,振幅分别为6.42%、5.85%、5.16%。乐普生物-B公司简介:乐普生物科技股份有限公司是一家专注于肿瘤治疗领域的中国生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404150938017a52a584&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404150938017a52a584&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427167095","title":"乐普生物(02157.HK)治疗晚期实体瘤药物临床试验完成首例受试者首次给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2427167095","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2427167095?lang=zh_cn&edition=full","pubTime":"2024-04-15 08:49","pubTimestamp":1713142140,"startTime":"0","endTime":"0","summary":"乐普生物-B公布,有关其与康诺亚-B成立的合营企业KYM与AstraZeneca订立许可协议以开发及商业化CMG901,目前,AstraZeneca已就CMG901治疗晚期实体瘤开展多项临床研究。当中,一项在表达Claudin 18.2的晚期或转移性胃及胃食管结合部腺癌受试者中比较CMG901单药与研究者选择的方案作为二线或二线以上治疗的国际多中心III期研究,已于今年3月在药物临床试验登记与信息平台进行公示,首例受试者已于4月11日完成首次给药。Claudin 18.2是治疗晚期胃癌或胃食管结合部腺癌颇具潜力的靶点。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20220330162715377_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20220330162715377_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1342111/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2427982040","title":"乐普生物-B(02157):AstraZeneca已就CMG901治疗晚期实体瘤开展多项临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2427982040","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2427982040?lang=zh_cn&edition=full","pubTime":"2024-04-15 08:14","pubTimestamp":1713140072,"startTime":"0","endTime":"0","summary":"智通财经APP讯,乐普生物-B 发布公告,有关KYM Biosciences Inc.与AstraZeneca AB就开发及商业化 CMG901而订立的全球独家许可协议的最新情况。于2023年2月,KYM与AstraZeneca订立许可协议,以开发及商业化CMG901。于签署许可协议后及在就许可交易取得若干监管批准后,AstraZeneca于2023年2月获授CMG901的研究、开发、注册、生产及商业化的独家全球许可,并须根据许可协议负责与其进一步开发及商业化相关的所有成本及活动。截至本公告日期,AstraZeneca已就CMG901治疗晚期实体瘤开展了多项临床研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1102285.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426477039","title":"乐普生物-B盘中异动 股价大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426477039","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426477039?lang=zh_cn&edition=full","pubTime":"2024-04-11 10:16","pubTimestamp":1712801796,"startTime":"0","endTime":"0","summary":"2024年04月11日早盘10时16分,乐普生物-B股票出现波动,股价快速拉升5.16%。截至发稿,该股报3.871港元/股,成交量46.8万股,换手率0.03%,振幅9.78%。乐普生物-B股票所在的生物技术行业中,整体跌幅为0.94%。其相关个股中,乐普生物-B、加科思-B、博安生物涨幅较大,振幅较大的相关个股有乐普生物-B、宜明昂科-B、科伦博泰生物-B,振幅分别为9.24%、7.77%、7.36%。乐普生物-B公司简介:乐普生物科技股份有限公司是一家专注于肿瘤治疗领域的中国生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404111016367a52095d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404111016367a52095d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426486221","title":"乐普生物-B(02157)上涨5.52%,报3.82元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426486221","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2426486221?lang=zh_cn&edition=full","pubTime":"2024-04-10 11:54","pubTimestamp":1712721250,"startTime":"0","endTime":"0","summary":"4月10日,乐普生物-B(02157)盘中上涨5.52%,截至11:54,报3.82元/股,成交189.29万元。乐普生物科技股份有限公司是一家专注于肿瘤治疗领域的创新型生物制药企业,主要通过自主创新和战略合作构建有市场差异化的生物药产品管线,并致力于建立并加强自主生产能力,实现产品的国内商业化和国际市场推广。截至2023年年报,乐普生物-B营业总收入2.25亿元、净利润-2209.6万元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/10115440178057.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2426489947","title":"乐普生物-B盘中异动 快速拉升5.52%报3.821港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426489947","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426489947?lang=zh_cn&edition=full","pubTime":"2024-04-10 11:54","pubTimestamp":1712721247,"startTime":"0","endTime":"0","summary":"2024年04月10日临近午盘11时54分,乐普生物-B股票出现异动,股价急速上涨5.52%。截至发稿,该股报3.821港元/股,成交量51.3万股,换手率0.03%,振幅8.56%。资金方面,该股资金流入151.956万港元,流出20.341万港元。乐普生物-B股票所在的生物技术行业中,整体涨幅为0.29%。乐普生物-B公司简介:乐普生物科技股份有限公司是一家专注于肿瘤治疗领域的中国生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041011540787e7f1da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041011540787e7f1da&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426489303","title":"乐普生物-B(02157)股价上升5.249%,现价港币$3.81","url":"https://stock-news.laohu8.com/highlight/detail?id=2426489303","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2426489303?lang=zh_cn&edition=full","pubTime":"2024-04-10 11:54","pubTimestamp":1712721240,"startTime":"0","endTime":"0","summary":"[上升股]乐普生物-B(02157) 股价在上午11:54比前收市价上升5.249%,现股价为港币$3.81。至目前为止,今日最高价为$3.81,而最低价为$3.51。总成交量为51.1万股,总成交金额为港币$188.524万。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2404103137/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2425984635","title":"乐普生物-B(02157)上涨5.12%,报3.49元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2425984635","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2425984635?lang=zh_cn&edition=full","pubTime":"2024-04-08 11:50","pubTimestamp":1712548240,"startTime":"0","endTime":"0","summary":"4月8日,乐普生物-B(02157)盘中上涨5.12%,截至11:50,报3.49元/股,成交155.65万元。乐普生物科技股份有限公司是一家专注于肿瘤治疗领域的创新型生物制药企业,主要通过自主创新和战略合作构建有市场差异化的生物药产品管线,并致力于建立并加强自主生产能力,实现产品的国内商业化和国际市场推广。截至2023年年报,乐普生物-B营业总收入2.25亿元、净利润-2209.6万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/08115040143823.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2425060984","title":"乐普生物-B盘中异动 快速上涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425060984","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425060984?lang=zh_cn&edition=full","pubTime":"2024-04-08 11:50","pubTimestamp":1712548233,"startTime":"0","endTime":"0","summary":"2024年04月08日临近午盘11时50分,乐普生物-B股票出现波动,股价大幅拉升5.12%。截至发稿,该股报3.491港元/股,成交量45.7万股,换手率0.03%,振幅5.72%。乐普生物-B股票所在的生物技术行业中,整体涨幅为0.89%。乐普生物-B公司简介:乐普生物科技股份有限公司是一家专注于肿瘤治疗领域的中国生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404081150347a5145af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404081150347a5145af&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425103984","title":"乐普生物-B(02157)股价上升5.12%,现价港币$3.49","url":"https://stock-news.laohu8.com/highlight/detail?id=2425103984","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2425103984?lang=zh_cn&edition=full","pubTime":"2024-04-08 11:50","pubTimestamp":1712548200,"startTime":"0","endTime":"0","summary":"[上升股]乐普生物-B(02157) 股价在上午11:50比前收市价上升5.12%,现股价为港币$3.49。至目前为止,今日最高价为$3.49,而最低价为$3.3。总成交量为44.8万股,总成交金额为港币$152.51万。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2404081856/aamm-all-category","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lepubiopharma.com","stockEarnings":[{"period":"1week","weight":0.1376},{"period":"1month","weight":0.3272},{"period":"3month","weight":0.4828},{"period":"6month","weight":0.1467},{"period":"1year","weight":-0.2081},{"period":"ytd","weight":0.0214}],"compareEarnings":[{"period":"1week","weight":-0.0415},{"period":"1month","weight":-0.0087},{"period":"3month","weight":0.0704},{"period":"6month","weight":-0.0458},{"period":"1year","weight":-0.1955},{"period":"ytd","weight":-0.0388}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"exchange":"SEHK","name":"乐普生物-B","nameEN":"LEPU BIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"乐普生物-B(02157)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供乐普生物-B(02157)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"乐普生物-B,02157,乐普生物-B股票,乐普生物-B股票老虎,乐普生物-B股票老虎国际,乐普生物-B行情,乐普生物-B股票行情,乐普生物-B股价,乐普生物-B股市,乐普生物-B股票价格,乐普生物-B股票交易,乐普生物-B股票购买,乐普生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"乐普生物-B(02157)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供乐普生物-B(02157)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}